颈泰胶囊(Jingtai Capsule) - _专利_临床

概要

基本信息

药物类型

中药

别名-

靶点-

作用机制-

治疗领域

神经系统疾病皮肤和肌肉骨骼疾病

在研适应症-

非在研适应症

肩痛退化性脊椎炎

原研机构-

在研机构-

非在研机构

陕西科迈药物开发有限公司

陕西东泰制药有限公司

最高研发阶段无进展临床3期

首次获批日期-

最高研发阶段(中国)无进展

特殊审评-

登录后查看时间轴

关联

2

项与颈泰胶囊相关的临床试验

CTR20130532 / Completed临床3期

以安慰剂为对照，评价颈泰胶囊治疗神经根型颈椎病（气滞血瘀证）有效性和安全性随机、双盲Ⅲ期临床试验

以安慰剂为对照，评价颈泰胶囊治疗神经根型颈椎病（气滞血瘀证）有效性和安全性的分层区组随机、双盲单模拟、多中心Ⅲ期临床试验

开始日期2014-03-30

申办/合作机构

陕西科迈药物开发有限公司

[+1]

CTR20130039 / Completed临床2期

以舒筋通络颗粒、安慰剂为对照，随机双盲双模拟评价颈泰胶囊治疗神经根型颈椎病的Ⅱ期临床试验

初步评价颈泰胶囊治疗神经根型颈椎病（气滞血瘀证）的临床有效性和安全性。

开始日期2012-06-02

申办/合作机构

陕西科迈药物开发有限公司

[+1]

100 项与颈泰胶囊相关的临床结果

登录后查看更多信息

100 项与颈泰胶囊相关的转化医学

登录后查看更多信息

100 项与颈泰胶囊相关的专利（医药）

登录后查看更多信息

3

项与颈泰胶囊相关的文献（医药）

2011-03-01·Journal of Traditional Chinese Medicine4区 · 医学

Effects of Jingyuankang Capsules () on Leukocyte Level in AIDS Patients

4区 · 医学

Article

作者: Hong-xin Sun ; Ying-min Xu ; Shi-qing Jiang ; Yan-ling Jiang ; Jun-wen Pei ; Hong-ling Wang

OBJECTIVETo observe the therapeutic effects of Jingyuankang capsules for leukopenia in AIDS patients.METHODSIn this randomized double-blind trial, 58 patients orally took Jingyuankang capsule, analog Leucogen tablet and the HAART (highly active anti-retroviral therapy) drugs, and the other 58 patients took Leucogen tablet, analog Jingyuankang capsule and the HAART drugs all for 6 months, during which the peripheral hemogram was periodically examined to observe the therapeutic effects of Jingyuankang capsule for leukopenia of the AIDS patients.RESULTSWith good therapeutic effect for leukopenia of the AIDS patients, Jingyuankang capsule can enhance leukocyte level as effective as Leucogen tablet in treating grade I and grade II leukopenia, and more effectively than Leucogen tablet in treating grade III leukopenia. No toxic side-effects and adverse reactions were found during the treatment and in the follow-up visit.CONCLUSIONJingyuankang capsule can effectively treat leukopenia of the AIDS patients.

2008-09-15·Journal of Chinese Integrative Medicine

Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy

Article

作者: Yang, Ji-jin ; Wang, Wei-xing ; Mao, Yan-jun ; Jiang, Xu ; Yang, Chao-ai ; Guo, Ji-xiang ; Zhang, Huo-jun

OBJECTIVETo observe and discuss the dynamic changes of interleukin-2 (IL-2) and soluble interleukin-2 receptor (sIL-2R) and their significance in the patients with primary liver cancer after transarterial chemoembolization (TACE) therapy combined with Jinglong Capsule.METHODSA total of 48 patients with primary liver cancer, who failed to be treated by major surgery, were randomly divided into two groups: Jinlong Capsule group (TACE therapy plus Jinlong Capsule) and control group (TACE therapy alone). There were 24 cases in each group. The levels of peripheral blood IL-2 and slL-2R were measured before the first TACE and 1, 7 and 15 days after the second TACE respectively by using double-antibody sandwich enzyme-linked immunosorbent assay. The data from Jinlong Capsule group were compared with those from the control group.RESULTSThe level of sIL-2R in Jinlong Capsule group was significantly lower than that in the control group (P<0.05), while the level of IL-2 was significantly higher than that in the control group (P<0.05).CONCLUSIONJinlong Capsule can significantly improve the lymphocyte function of the patients with primary liver cancer after TACE. The levels of IL-2 and sIL-2R can be considered as the valuable parameters for evaluating the effects on primary liver cancer, and Jinlong Capsule is helpful for the patients with primary liver cancer.

2008-01-01·The American Journal of Drug and Alcohol Abuse3区 · 医学

A Comparative Clinical Study of the Effects of the Traditional Chinese Medicine Jinniu Capsules and Lofexidine on Acute Heroin Withdrawal Symptoms

3区 · 医学

Article

作者: Hao, Wei ; Shi, Jie ; Xu, Guo-zhu ; Li, Jing ; Lu, Lin ; Chen, Hong-xian ; Li, Su-xia ; Shen, Li-yang ; Liu, Ting-ting ; Wang, Xi

OBJECTIVEJinniu capsules, comprised of herbs and marine product extracts, are traditionally used in Chinese medicine. In this randomized multicenter clinical trial we evaluated the efficacy and safety of Jinniu capsules used to treat the symptoms of heroin withdrawal, as compared with lofexidine.METHODSTwo hundred and twelve patients with heroin dependence were randomly assigned to the Jinniu capsule or lofexidine treatment groups during a 10-day double-blind clinical trial. The severity of their opiate withdrawal symptoms was measured daily for 10 days. Anxiety was measured on days 0, 5, and 10. Safety assessment of the drugs included measurement of vital signs and side effects, as well as laboratory tests.RESULTSWithdrawal symptom and anxiety scores decreased gradually over the treatment period, and no significant differences were found between two groups. No severe adverse events occurred during the treatment.CONCLUSIONJinniu capsules may be an effective and safe agent in the management of opiate withdrawal.

100 项与颈泰胶囊相关的药物交易

登录后查看更多信息

研发状态

10 条进展最快的记录,

登录

后查看更多信息

适应症	最高研发状态	国家/地区	公司	日期
肩痛	临床3期	中国	陕西科迈药物开发有限公司	2014-03-30
肩痛	临床3期	中国	陕西东泰制药有限公司	2014-03-30
退化性脊椎炎	临床3期	中国	陕西东泰制药有限公司	2014-03-30
退化性脊椎炎	临床3期	中国	陕西科迈药物开发有限公司	2014-03-30